Back to search
Super-Refractory Status Epilepticus
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Super-Refractory Status Epilepticus trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Super-Refractory Status Epilepticus trials you may qualify forThe purpose of the study is to investigate to evaluate the efficacy and safety of ketogenic diet (KD) as an adjunctive therapy in patients with Super Refractory…
Status epilepticus (SE) is found in 20-30% of patients in coma after cardiac arrest, is often refractory to medical therapy and is considered a negative prognos…
This is a randomized, double-blind, placebo-controlled trial, designed to evaluate the efficacy and safety of SAGE-547 administered as a continuous intravenous…
Isoflurane might be used as anticonvulsive therapy in refractory status epilepticus. The aim of the study is to assess the efficiency of Isoflurane in this indi…
This is an open-label, expanded access protocol, designed to offer treatment with SAGE-547 to subjects in SRSE, and to evaluate the efficacy and safety of SAGE-…